MIAMI, Feb. 13, 2012 /PRNewswire/ -- Attorneys representing many of the passengers who were aboard the doomed Costa Concordia Cruise Ship that capsized off the Italian coast in January are filing an Amended Complaint on behalf of thirty-nine individual plaintiffs in State Court before the Florida Circuit Court (11th Judicial Circuit) in Miami-Dade County. Although previous reports indicated a class action was filed, this is incorrect; no class certification is sought as the respective losses and injuries suffered by each plaintiff is unique. The initial complaint in the matter styled Scimone v. Carnival Cruise Lines, et al., under docket number 12-3496 CA 4 was filed for individually named plaintiffs on January 27, 2012.
The newly filed Amended Complaint has been transferred to the Court's Complex Litigation Division with an updated docket designation of CA 40. Plaintiffs are represented by the law firms Napoli Bern Ripka Shkolnik & Associates, LLP (with offices in New York and Florida), New York-based Proner & Proner and Florida law firm Colson Hicks Eidson along with the Italian firm CODACONS.
The factual recitation in the complaints sets forth the terrifying and catastrophic failings of the Carnival Cruise Lines' crew and training on the night of the incident, including the Captain's failure to sound an immediate alarm to alert the passengers when the accident occurred. Upon impact, passengers report that all of the ships lights went dark and that the Captain and much of his crew abandoned the passengers to their own devices by running from the darkened and badly listing ship with their luggage in hand, leaving the passengers in the dark without guidance and with at least half of the available life boats submerged under the grounded ship. The corporations responsible, Carnival Corporation, Costa Cruise Lines, Inc., and Costa Crociere SPA, are all registered in the State of Florida and face state law claims for Maritime Negligence, Gross Negligence, Intentional Infliction of Emotional Distress, and Negligent Retention (by the Cruise Line of Captain Schettino), the Amended Complaint sets forth new causes of action including Fraudulent Misrepresentation and Fraudulent Inducement; the plaintiffs will seek punitive damages as a result of the nature of the conduct of the Costa Concordia's officers and staff, which demonstrated a reckless disregard for human life and property.
Lead Plaintiffs' Attorney Marc Jay Bern said Monday that "these passengers were left terrified and unguided in a desperate situation while the Captain was already safely in a lifeboat with his clothes dry and his luggage in hand. Once the surviving passengers reached land, their ordeal was far from over because Carnival failed to offer them the barest courtesies and assistance, leaving them in a country where most were aliens, with only the clothes on their back, no money and no passports." More details will be provided when Bern and his colleagues hold a press conference on Tuesday, February 14, 2012 outside the 11th Judicial Circuit Courthouse, 175 Northwest 1st Avenue, Miami, Florida at 3:00 p.m.
This release was issued through WebWire(R). For more information visit http://www.webwire.com.
Press Release Contact Information:Marc Jay BernSenior Partner, Napoli Bern Ripka Shkolnik & Associates, LLPNapoli Bern Ripka Shkolnik & Associates, LLP(516) 361-4909mjbern@napolibern.com
SOURCE Napoli Bern Ripka Shkolnik & Associates, LLP
NEW YORK, NY -- (MARKET WIRE) -- 02/13/12 -- The total market for handheld devices in healthcare reached $11 billion globally in 2011, reflecting over 10% growth since 2007, according to Kalorama Information. There are a number of factors fueling growth, but the healthcare market research publisher sees the fastest growth in administrative devices -- the kind of devices used by healthcare providers to enter patient data -- as a sign that 'meaningful use' requirements for EMR systems are having an effect on this market.
The EMR incentive program, created by Health and Human Services (HHS) in 2009 to boost paperless medicine, was specifically designed not to reward mere purchases of software. To qualify for federal government incentives, hospital and physician groups are required to show that they have entered patient visits and transactions electronically.
"To qualify you have to show that your healthcare providers are actually using the EMR -- entering patient data and ordering prescriptions electronically," Kalorama Information publisher Bruce Carlson said. "We think that realistically it means handheld devices. Meaningful use of EMR means meaningful use of handhelds, as the patient-centered nature of healthcare work doesn't permit a lot of desk time."
Kalorama Information divides the market for handheld devices between patient monitoring and administrative use. Patient monitoring devices such as ultrasound and ECG systems have historically accounted for the largest share of sales in the handheld market, largely due to the range of product availability. However, this is changing with the growing applications and capabilities of tablet PCs, and the need to enter patient data electronically. Administrative device usage has exploded over the last five years with the growing use of PDAs, smartphones, and tablet PCs taking hold in the healthcare industry. Tablet PCs are being used for a variety of uses in the health field, including access to patient records at the point of care, improved viewing capabilities for medical images, and easy offsite patient monitoring.
EMR is not the only driver of handheld devices in healthcare. Several factors are driving the growth of this market, including cost restraints, medical error reduction measures, government incentives, expanding capabilities of devices, off-site medical care and more, according to Kalorama Information.
"The use of handheld devices in healthcare was growing before the first EMR payments were wired," said Carlson. "Better patient outcomes and the ability of providers to always have a patient record in front of them; these factors have driven purchases even more."
More information can be obtained in Kalorama Information's report on the subject, Handhelds in Healthcare: Markets for Smartphones, Tablet PCs, PDAs, Monitors & Scanners. The report includes key company profiles and market share, revenue forecasts, and breakouts by device category.
About Kalorama Information Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Please direct all media inquiries to: Bruce Carlson press@kaloramainformation.com www.KaloramaInformation.com
Source: Kalorama Information
Net Revenue Increases 17.6% to $1.58 Billion in the 4th Quarter
NAPLES, Fla.--(BUSINESS WIRE)-- Health Management Associates, Inc. (NYSE: HMA) today announced its consolidated financial results for the fourth quarter and year ended December 31, 2011.
Key metrics from continuing operations for the fourth quarter (all percentage changes compare the fourth quarter of 2011 to the fourth quarter of 2010) include:
- Excluding certain write-offs of deferred debt issuance costs, Tennova restructuring charges, and interest rate swap accounting, as shown in the tables accompanying this press release, diluted earnings per share from continuing operations increased 62.5% to $0.26 as compared to $0.16 per diluted share for the same quarter a year ago;
- Revenue increased 17.6% to $1.584 billion;
- Adjusted EBITDA increased 27.3% to $236.2 million. Adjusted EBITDA includes approximately $38.2 million of Medicare and Medicaid HCIT incentive payments, and excludes $24.6 million of write-offs of deferred debt issuance costs and $12.9 million of Tennova restructuring charges;
- Admissions increased 6.8% while adjusted admissions increased 11.6%;
- Same hospital net revenue increased 5.5% to $1,420.4 million;
- Same hospital net revenue per adjusted admission increased 6.6%;
- Same hospital Adjusted EBITDA increased 25.3% to $271.6 million, resulting in a 300 basis point improvement in margin to 19.1%. Excluding approximately $38.2 million of Medicare and Medicaid HCIT incentive payments, same hospital Adjusted EBITDA increased 7.7% to $233.3 million, resulting in a 30 basis point improvement in margin to 16.4%; and
- Same hospital surgeries increased 0.8%.
The tables accompanying this press release include reconciliations of consolidated net income to all presentations of Adjusted EBITDA (which is not a GAAP measure) contained in this press release. Those tables also reconcile earnings per share on a GAAP basis to those amounts presented in this press release and contain disclaimers and other important information regarding how Health Management defines and uses Adjusted EBITDA.
For continuing operations at hospitals operated by Health Management for one year or more, referred to as same hospital operations, net revenue in the fourth quarter increased $73.9 million or 5.5%, to $1,420.4 million compared to the same quarter in the prior year. Adjusted EBITDA from same hospital operations grew 25.3% to $271.6 million, representing 19.1% of net revenue, as compared to $216.7 million and 16.1%, respectively, for the same quarter a year ago. Same hospital Adjusted EBITDA includes $38.2 million of Medicare and Medicaid HCIT incentive payments and excludes $24.6 million of write-offs of deferred debt issuance costs and $12.9 million of Tennova restructuring charges. Declines in uninsured admissions contributed to a 3.7% and 1.1% decline in fourth quarter same hospital admissions and adjusted admissions, respectively.
“We are pleased to report another year of record revenues and strong earnings as we continue to successfully execute our operating and partnership strategies,” said Gary D. Newsome, Health Management’s President and Chief Executive Officer. “By continuing to focus our efforts on the fundamentals – investment in innovative services and strategic partnerships, recruitment of physicians and leadership talent, adherence to effective cost control measures and development of our very active partnership pipeline, we are looking forward to 2012 as we seek to enable America’s best local health care.”
Health Management’s provision for doubtful accounts, or bad debt expense, was $195.1 million, or 12.3% of net revenue, for the fourth quarter compared to $163.9 million, or 12.2% of net revenue, for the same quarter a year ago.
Uninsured self-pay patient discounts for the fourth quarter were $254.5 million, compared to $209.3 million for the same quarter a year ago. Charity/indigent care write-offs were $23.1 million for the fourth quarter, compared to $24.2 million for the same quarter a year ago.
The sum of uninsured discounts, charity/indigent write-offs and bad debt expense, as a percent of the sum of net revenue, uninsured discounts and charity/indigent write-offs (which Health Management refers to as its Uncompensated Patient Care Percentage) was 25.4% for the fourth quarter, compared to 25.2% for the fourth quarter a year ago, and 26.1% for the quarter ended September 30, 2011. Health Management believes that its Uncompensated Patient Care Percentage provides key information regarding the aggregate level of patient care for which it does not receive payment.
Cash flow from continuing operating activities for the fourth quarter was $114.8 million, after cash interest and cash tax payments aggregating $59.9 million. Health Management’s total leverage ratio and interest coverage ratio were both approximately 4.0 at December 31, 2011.
For the year ended December 31, 2011, Health Management reported net revenue of $5,804.5 million and Adjusted EBITDA of $848.2 million. For 2011, income from continuing operations was $206.3 million and net income attributable to Health Management’s common stockholders was $178.7 million, or $0.71 per diluted share from continuing operations, a 9.2% increase compared to $0.65 per diluted share from continuing operations for the year ended December 31, 2010. As shown in the accompanying table, excluding write-offs of deferred debt issuance costs, interest rate swap accounting, Tennova restructuring charges and acquisition and investigation charges, diluted earnings per share from continuing operations increased 32.3% to $0.86 compared to the same period a year ago.
Health Management hospitals recognized approximately $1.8 million of Medicare and Medicaid HCIT incentive payments in the third quarter ended September 30, 2011 and approximately $38.2 million in the fourth quarter ended December 31, 2011. Based on current 2012 attestation schedules and cost report year ends for the remainder of its hospitals, Health Management expects to recognize approximately $90 to $120 million of Medicare and Medicaid HCIT incentive payments during the year ending December 31, 2012, the bulk of which is expected to be recorded in the third and fourth quarters of 2012.
Health Management is also affirming its diluted EPS from continuing operations objective range for fiscal year 2012 to be between $0.80 and $0.90. This diluted EPS range does not include approximately $80 million, or $0.20 per diluted share of impact expected from interest rate swap accounting or approximately $90 to $120 million of anticipated Medicare and Medicaid HCIT incentive payments.
As previously announced on February 6, 2012, a subsidiary of Health Management executed a definitive agreement with INTEGRIS Health to enter into a joint venture arrangement for five Oklahoma hospitals. The Oklahoma hospitals to be joint ventured include: 53-bed Integris Blackwell Regional Hospital, located in Blackwell; 64-bed Integris Clinton Regional Hospital, located in Clinton; 25-bed Integris Marshall County Medical Center, located in Madill; 52-bed Integris Mayes County Medical Center, located in Pryor; and 32-bed Integris Seminole Medical Center, located in Seminole. Combined, these five hospitals have an aggregate of 226 licensed beds and generated approximately $95 million of revenue over the last twelve months. Under the joint venture agreement, Health Management is anticipated to own an 80% controlling interest in each of these five hospitals and will manage their operations. The transaction is subject to normal and customary regulatory approvals and is expected to be completed by April 1, 2012.
Health Management’s executive team will hold a conference call and webcast to discuss the contents of this press release and Health Management’s consolidated financial results for the three months and year ended December 31, 2011 on Tuesday, February 14, 2012 at 11:00 a.m. EST. Investors are invited to access the webcast via Health Management’s website at www.HMA.com or via www.streetevents.com. Alternatively, investors may join the conference call by dialing 877-476-3476.
Health Management will archive a copy of the audio webcast of the conference call, along with any related information that Health Management may be required to provide pursuant to Securities and Exchange Commission rules, on its website under the heading “Investor Relations” for a period of 60 days following the conference call.
Health Management enables America's best local health care by providing the people, processes, capital and expertise necessary for its hospital and physician partners to fulfill their local missions of delivering superior health care services. Health Management, through its subsidiaries and upon completion of the previously announced INTEGRIS Health joint venture transaction, will operate 71 hospitals, with approximately 10,600 licensed beds, in non-urban communities located throughout the United States.
All references to "Health Management," "HMA" or the "Company" used in this release refer to Health Management Associates, Inc. and its affiliates.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects," "estimates," "projects," "anticipates," "believes," "plans," "could" and other similar words. All statements addressing operating performance, events or developments that Health Management Associates, Inc. expects or anticipates will occur in the future, including but not limited to incurrence of indebtedness, projections of revenue, income or loss, capital expenditures, earnings per share, the timing and receipt of Medicare and Medicaid HCIT incentive payments the financial impact expected from interest rate swap accounting, debt structure, bad debt expense, capital structure, repayment of indebtedness, other financial items and operating statistics, statements regarding the plans and objectives of management for future operations, innovations, or market service development, statements regarding acquisitions, joint ventures, divestitures and other proposed or contemplated transactions (including but not limited to statements regarding the timing of anticipated acquisitions, the potential for future acquisitions and perceived benefits of acquisitions), statements of future economic performance, statements regarding the effects and/or interpretations of recently enacted or future health care laws and regulations, statements of the assumptions underlying or relating to any of the foregoing statements, and other statements which are other than statements of historical fact, are considered to be "forward-looking statements."
Because they are forward-looking, such statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Health Management Associates, Inc.'s most recent Annual Report on Form 10-K, and its most recent Quarterly Report on Form 10-Q, under the headings entitled "Risk Factors." Should one or more of these risks or uncertainties materialize, or should any of Health Management Associates, Inc.'s underlying assumptions prove incorrect, actual results could vary materially from those currently anticipated. In addition, undue reliance should not be placed on Health Management Associates, Inc.'s forward-looking statements. Except as required by law, Health Management Associates, Inc. disclaims any obligation to update its risk factors or to publicly announce updates to the forward-looking statements contained in this press release to reflect new information, future events or other developments.
|
HEALTH MANAGEMENT ASSOCIATES, INC. CONSOLIDATED STATEMENTS OF INCOME (unaudited, in thousands, except per share amounts) |
||||||||||||||||
| Three Months Ended | Twelve Months Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||
| Net revenue | $ | 1,583,774 | $ | 1,346,549 | $ | 5,804,451 | $ | 5,092,166 | ||||||||
| Salaries and benefits | 637,751 | 539,147 | 2,302,844 | 2,016,967 | ||||||||||||
| Supplies | 216,350 | 178,546 | 776,598 | 703,426 | ||||||||||||
| Provision for doubtful accounts | 195,127 | 163,946 | 716,856 | 624,753 | ||||||||||||
| Rent expense | 43,541 | 33,710 | 154,279 | 122,983 | ||||||||||||
| Other operating expenses | 305,865 | 245,636 | 1,067,980 | 892,465 | ||||||||||||
| Medicare and Medicaid HCIT incentive payments | (38,233 | ) | - | (39,982 | ) | - | ||||||||||
| Depreciation and amortization | 73,466 | 61,258 | 267,900 | 241,873 | ||||||||||||
| Interest expense | 70,659 | 52,742 | 222,747 | 211,673 | ||||||||||||
| Write-off of deferred debt issuance costs | 24,595 | - | 24,595 | - | ||||||||||||
| Other | 12 | (689 | ) | (1,771 | ) | (8,797 | ) | |||||||||
| 1,529,133 | 1,274,296 | 5,492,046 | 4,805,343 | |||||||||||||
| Income from continuing operations before income taxes | 54,641 | 72,253 | 312,405 | 286,823 | ||||||||||||
| Provision for income taxes | (16,893 | ) | (26,041 | ) | (106,071 | ) | (101,049 | ) | ||||||||
| Income from continuing operations | 37,748 | 46,212 | 206,334 | 185,774 | ||||||||||||
| Loss from discontinued operations, net of income taxes | (1,227 | ) | (12,976 | ) | (2,409 | ) | (13,526 | ) | ||||||||
| Consolidated net income | 36,521 | 33,236 | 203,925 | 172,248 | ||||||||||||
| Net income attributable to noncontrolling interests | (5,674 | ) | (5,057 | ) | (25,215 | ) | (22,179 | ) | ||||||||
| Net income attributable to Health Management Associates, Inc. | $ | 30,847 | $ | 28,179 | $ | 178,710 | $ | 150,069 | ||||||||
| Earnings (loss) per share attributable to Heath Management | ||||||||||||||||
| Associates, Inc. common stockholders: | ||||||||||||||||
| Basic: | ||||||||||||||||
| Continuing operations | $ | 0.13 | $ | 0.17 | $ | 0.72 | $ | 0.66 | ||||||||
| Discontinued operations | - | (0.05 | ) | (0.01 | ) | (0.05 | ) | |||||||||
| Net income | $ | 0.13 | $ | 0.12 | $ | 0.71 | $ | 0.61 | ||||||||
| Diluted: | ||||||||||||||||
| Continuing operations | $ | 0.13 | $ | 0.16 | $ | 0.71 | $ | 0.65 | ||||||||
| Discontinued operations | - | (0.05 | ) | (0.01 | ) | (0.05 | ) | |||||||||
| Net income | $ | 0.13 | $ | 0.11 | $ | 0.70 | $ | 0.60 | ||||||||
| Weighted average number of shares outstanding: | ||||||||||||||||
| Basic | 252,175 | 248,600 | 251,541 | 248,272 | ||||||||||||
| Diluted | 256,032 | 252,372 | 255,037 | 251,106 | ||||||||||||
| Net income attributable to Health Management Associates, Inc. | ||||||||||||||||
| Income from continuing operations, net of income taxes | $ | 32,074 | $ | 41,155 | $ | 181,119 | $ | 163,595 | ||||||||
| Loss from discontinued operations, net of income taxes | (1,227 | ) | (12,976 | ) | (2,409 | ) | (13,526 | ) | ||||||||
| Net income attributable to Health Management Associates, Inc. | $ | 30,847 | $ | 28,179 | $ | 178,710 | $ | 150,069 | ||||||||
|
HEALTH MANAGEMENT ASSOCIATES, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited, in thousands) |
|||||||||||
| Twelve Months Ended December 31, | |||||||||||
| 2011 | 2010 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Consolidated net income | $ | 203,925 | $ | 172,248 | |||||||
| Adjustments to reconcile consolidated net income to net cash | |||||||||||
| provided by continuing operating activities: | |||||||||||
| Depreciation and amortization | 274,526 | 248,583 | |||||||||
| Amortization related to interest rate swap contract | 10,384 | - | |||||||||
| Fair value adjustment related to interest rate swap contract | 5,979 | - | |||||||||
| Provision for doubtful accounts | 716,856 | 624,753 | |||||||||
| Stock-based compensation expense | 25,169 | 18,366 | |||||||||
| Losses (gains) on sales of assets, net | 1,325 | (711 | ) | ||||||||
| Gains on sales of available-for-sale securities, net | (518 | ) | (4,328 | ) | |||||||
| Write-off of deferred debt issuance costs | 24,045 | - | |||||||||
| Deferred income tax expense | 79,159 | 20,311 | |||||||||
| Changes in assets and liabilities of continuing operations, | |||||||||||
| net of the effects of acquisitions: | |||||||||||
| Accounts receivable | (870,898 | ) | (731,607 | ) | |||||||
| Supplies, prepaid expenses and other current assets | (11,379 | ) | (20,643 | ) | |||||||
| Prepaid and recoverable income taxes | (18,987 | ) | 31,020 | ||||||||
| Deferred charges and other long-term assets | (5,785 | ) | 5,382 | ||||||||
| Accounts payable, accrued expenses and other liabilities | 128,521 | 59,069 | |||||||||
| Equity compensation excess income tax benefits | (2,999 | ) | (1,278 | ) | |||||||
| Loss from discontinued operations, net of income taxes | 2,409 | 13,526 | |||||||||
| Net cash provided by continuing operating activities | 561,732 | 434,691 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Acquisitions of hospitals and other | (582,090 | ) | (191,454 | ) | |||||||
| Additions to property, plant and equipment | (302,046 | ) | (209,108 | ) | |||||||
| Proceeds from sales of assets and insurance recoveries | 2,765 | 3,150 | |||||||||
| Proceeds from sales of discontinued operations | 4,851 | 26,360 | |||||||||
| Purchases of available-for-sale securities | (1,385,580 | ) | (921,724 | ) | |||||||
| Proceeds from sales of available-for-sale securities | 1,321,398 | 904,881 | |||||||||
| Increase in restricted funds | (35,309 | ) | (5,758 | ) | |||||||
| Net cash used in continuing investing activities | (976,011 | ) | (393,653 | ) | |||||||
| Cash flows from financing activities: | |||||||||||
| Proceeds from long-term borrowings | 3,356,970 | - | |||||||||
| Principal payments on debt and capital lease obligations | (2,869,380 | ) | (40,147 | ) | |||||||
| Proceeds from exercises of stock options | 14,067 | 7,469 | |||||||||
| Payments for debt issuance costs | (75,149 | ) | - | ||||||||
| Cash received from noncontrolling shareholders | - | 2,547 | |||||||||
| Cash payments to noncontrolling shareholders | (28,284 | ) | (20,630 | ) | |||||||
| Equity compensation excess income tax benefits | 2,999 | 1,278 | |||||||||
| Net cash provided by (used in) continuing financing activities | 401,223 | (49,483 | ) | ||||||||
| Net decrease in cash and cash equivalents before | |||||||||||
| discontinued operations | (13,056 | ) | (8,445 | ) | |||||||
| Net increases (decreases) in cash and cash equivalents | |||||||||||
| from discontinued operations: | |||||||||||
| Operating activities | 5,991 | 5,672 | |||||||||
| Investing activities | (12,894 | ) | (1,433 | ) | |||||||
| Net decrease in cash and cash equivalents | (19,959 | ) | (4,206 | ) | |||||||
| Cash and cash equivalents at the beginning of the period | 101,812 | 106,018 | |||||||||
| Cash and cash equivalents at the end of the period | $ | 81,853 | $ | 101,812 | |||||||
|
HEALTH MANAGEMENT ASSOCIATES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS AND STATISTICS |
||||||
| December 31, | December 31, | |||||
| 2011 | 2010 | |||||
| (unaudited, in thousands) | ||||||
| Assets | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | $ | 81,853 | $ | 101,812 | ||
| Available-for-sale securities | 122,277 | 57,327 | ||||
| Accounts receivable, net | 903,517 | 759,131 | ||||
| Other current assets | 305,640 | 268,726 | ||||
| Assets of discontinued operations | 14,561 | 11,384 | ||||
| Property, plant and equipment, net | 3,263,172 | 2,662,947 | ||||
| Restricted funds | 96,244 | 51,067 | ||||
| Other assets | 1,234,635 | 997,691 | ||||
| Total assets | $ | 6,021,899 | $ | 4,910,085 | ||
| Liabilities and Stockholders' Equity | ||||||
| Current liabilities | $ | 821,534 | $ | 555,630 | ||
| Deferred income taxes | 234,080 | 157,177 | ||||
| Other long-term liabilities | 691,680 | 680,073 | ||||
| Long-term debt | 3,489,489 | 2,983,719 | ||||
| Stockholders' equity | 785,116 | 533,486 | ||||
| Total liabilities and stockholders' equity | $ | 6,021,899 | $ | 4,910,085 | ||
| Three Months Ended December 31, | Twelve Months Ended December 31, | |||||||||||||||||||||
| 2011 | 2010 | % Change | 2011 | 2010 | % Change | |||||||||||||||||
| Continuing Operations | ||||||||||||||||||||||
| Occupancy | 41.0 | % | 42.7 | % | 42.8 | % | 43.9 | % | ||||||||||||||
| Patient days | 364,916 | 342,909 | 6.4 | % | 1,424,500 | 1,350,697 | 5.5 | % | ||||||||||||||
| Admissions | 88,330 | 82,734 | 6.8 | % | 338,637 | 323,917 | 4.5 | % | ||||||||||||||
| Adjusted admissions | 169,200 | 151,548 | 11.6 | % | 635,934 | 586,060 | 8.5 | % | ||||||||||||||
| Average length of stay | 4.1 | 4.1 | 4.2 | 4.2 | ||||||||||||||||||
| Surgeries | 95,429 | 80,869 | 18.0 | % | 342,421 | 314,564 | 8.9 | % | ||||||||||||||
| Emergency room visits | 416,627 | 370,821 | 12.4 | % | 1,562,028 | 1,413,831 | 10.5 | % | ||||||||||||||
| Net revenue (in thousands) | $ | 1,583,774 | $ | 1,346,549 | 17.6 | % | $ | 5,804,451 | $ | 5,092,166 | 14.0 | % | ||||||||||
| Net revenue per adjusted admission | $ | 9,360 | $ | 8,885 | 5.3 | % | $ | 9,127 | $ | 8,689 | 5.0 | % | ||||||||||
| Total inpatient revenue percentage | 47.7 | % | 49.5 | % | 48.1 | % | 50.0 | % | ||||||||||||||
| Total outpatient revenue percentage | 52.3 | % | 50.5 | % | 51.9 | % | 50.0 | % | ||||||||||||||
| Same Hospitals | ||||||||||||||||||||||
| Occupancy | 40.7 | % | 42.7 | % | 42.1 | % | 43.9 | % | ||||||||||||||
| Patient days | 328,340 | 342,909 | -4.2 | % | 1,300,722 | 1,350,697 | -3.7 | % | ||||||||||||||
| Admissions | 79,646 | 82,734 | -3.7 | % | 311,053 | 323,917 | -4.0 | % | ||||||||||||||
| Adjusted admissions | 149,947 | 151,548 | -1.1 | % | 581,056 | 586,060 | -0.9 | % | ||||||||||||||
| Average length of stay | 4.1 | 4.1 | 4.2 | 4.2 | ||||||||||||||||||
| Surgeries | 81,502 | 80,869 | 0.8 | % | 316,298 | 314,564 | 0.6 | % | ||||||||||||||
| Emergency room visits | 368,461 | 370,821 | -0.6 | % | 1,430,193 | 1,413,831 | 1.2 | % | ||||||||||||||
| Net revenue (in thousands) | $ | 1,420,432 | $ | 1,346,549 | 5.5 | % | $ | 5,335,498 | $ | 5,092,166 | 4.8 | % | ||||||||||
| Net revenue per adjusted admission | $ | 9,473 | $ | 8,885 | 6.6 | % | $ | 9,182 | $ | 8,689 | 5.7 | % | ||||||||||
| Total inpatient revenue percentage | 47.8 | % | 49.5 | % | 48.4 | % | 50.0 | % | ||||||||||||||
| Total outpatient revenue percentage | 52.2 | % | 50.5 | % | 51.6 | % | 50.0 | % | ||||||||||||||
|
HEALTH MANAGEMENT ASSOCIATES, INC. SUPPLEMENTAL CONSOLIDATED STATEMENTS OF INCOME INFORMATION (unaudited, in thousands) |
||||||||||||||||
| Three Months Ended | Twelve Months Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||
| Net revenue | $ | 1,583,774 | $ | 1,346,549 | $ | 5,804,451 | $ | 5,092,166 | ||||||||
| Less acquisitions | 163,342 | - | 468,953 | - | ||||||||||||
| Same hospital net revenue | $ | 1,420,432 | $ | 1,346,549 | $ | 5,335,498 | $ | 5,092,166 | ||||||||
| Consolidated net income | $ | 36,521 | $ | 33,236 | $ | 203,925 | $ | 172,248 | ||||||||
| Adjustments: | ||||||||||||||||
| Loss from discontinued operations, net of income taxes | 1,227 | 12,976 | 2,409 | 13,526 | ||||||||||||
| Provision for income taxes | 16,893 | 26,041 | 106,071 | 101,049 | ||||||||||||
| (Gains) losses on sales of assets, net | 229 | 133 | 1,325 | (711 | ) | |||||||||||
| Interest and other income, net | (217 | ) | (822 | ) | (3,096 | ) | (8,086 | ) | ||||||||
| Interest expense | 70,659 | 52,742 | 222,747 | 211,673 | ||||||||||||
| Write-off of deferred debt issuance costs | 24,595 | - | 24,595 | - | ||||||||||||
| Costs for acquisitions, investigations and restructuring (a) | 12,869 | 83 | 22,324 | 883 | ||||||||||||
| Depreciation and amortization | 73,466 | 61,258 | 267,900 | 241,873 | ||||||||||||
| Adjusted EBITDA (b) | 236,242 | 185,647 | 848,200 | 732,455 | ||||||||||||
| Adjustment for acquisitions, corporate and other | 35,312 | 31,069 | 106,826 | 127,369 | ||||||||||||
| Same hospital operating Adjusted EBITDA (b) | $ | 271,554 | $ | 216,716 | $ | 955,026 | $ | 859,824 | ||||||||
| Same hospital operating Adjusted EBITDA margins = | ||||||||||||||||
| Same hospital operating Adjusted EBITDA / Same hospital net revenue (b) | 19.1 | % | 16.1 | % | 17.9 | % | 16.9 | % | ||||||||
| (a) For purposes of calculating Adjusted EBITDA as further defined below, Health Management has not included any investigation costs for the three months ended December 31, 2011, while for the year ended December 31, 2011, approximately $4.5 million of investigation costs have been included. | |
|
(b) Adjusted EBITDA is defined as consolidated net income before discontinued operations, net gains (losses) on sales of assets, net interest and other income, interest expense, income taxes, costs for acquisitions, investigations and restucturing, write-offs of deferred debt issuance costs, and depreciation and amortization. Adjusted EBITDA margin is defined as Adjusted EBITDA divided by net revenue. Adjusted EBITDA is not a measure determined in accordance with generally accepted accounting principles in the United States, commonly known as GAAP. Nevertheless, Health Management believes that providing non-GAAP information such as Adjusted EBITDA is important for investors and other readers of Health Management's consolidated financial statements as it is commonly used as an analytical indicator within the health care industry and Health Management's debt facilities contain covenants that use Adjusted EBITDA in their calculations. Because Adjusted EBITDA is a non-GAAP measure and is thus susceptible to varying calculations, Adjusted EBITDA, as presented, may not be directly comparable to other similarly titled measures used by other companies. |
|
|
HEALTH MANAGEMENT ASSOCIATES, INC. SUPPLEMENTAL CONSOLIDATED STATEMENTS OF INCOME INFORMATION (unaudited, in thousands, except per share amounts) |
|||||||||
|
The following tables provide information regarding income from continuing operations attributable to Health Management, excluding the impact of write-off of deferred debt issuance costs, interest rate swap amortization and mark-to-market adjustment, and acquisition, investigation and restructuring costs. These tables are a non-GAAP presentation; nonetheless, Health Management believes that providing this detail is beneficial to investors and other readers of Health Management's consolidated financial statements due to the significant impact these items had on income from continuing operations attributable to Health Management. |
|||||||||
| Three Months Ended December 31, 2011 | |||||||||
| Write-Off of | Interest Rate Swap | Acquisition, | |||||||
| Deferred | Amortization and | Investigation and | |||||||
| Continuing | Debt Issuance | Mark-To-Market | Restructuring | Total, As | |||||
| Operations | Costs | Adjustment | Costs | Reported | |||||
| Income from continuing operations before income taxes | |||||||||
| $ 108,468 | $ (24,595) | $ (16,363) | $ (12,869) | $ 54,641 | |||||
| Net income from continuing operations attributable to noncontrolling interests | |||||||||
| (5,674) | - | - | - | (5,674) | |||||
| Income from continuing operations before income taxes attributable to Health Management Associates, Inc. | |||||||||
| 102,794 | (24,595) | (16,363) | (12,869) | 48,967 | |||||
| Provision for income taxes | (37,752) | 9,531 | 6,341 | 4,987 | (16,893) | ||||
| Income from continuing operations attributable to Health Management Associates, Inc. common stockholders | |||||||||
| $ 65,042 | $ (15,064) | $ (10,022) | $ (7,882) | $ 32,074 | |||||
| Earnings per share from continuing operations attributable to Health Management Associates, Inc. common stockholders: | |||||||||
| Basic | $ 0.26 | $ (0.06) | $ (0.04) | $ (0.03) | $ 0.13 | ||||
| Diluted | $ 0.26 | $ (0.06) | $ (0.04) | $ (0.03) | $ 0.13 | ||||
| Twelve Months Ended December 31, 2011 | |||||||||
| Write-Off of | Interest Rate Swap | Acquisition, | |||||||
| Deferred | Amortization and | Investigation and | |||||||
| Continuing | Debt Issuance | Mark-To-Market | Restructuring | Total, As | |||||
| Operations | Costs | Adjustment | Costs | Reported | |||||
| Income from continuing operations before income taxes | |||||||||
| $ 375,687 | $ (24,595) | $ (16,363) | $ (22,324) | $ 312,405 | |||||
| Net income from continuing operations attributable to noncontrolling interests | |||||||||
| (25,215) | - | - | - | (25,215) | |||||
| Income from continuing operations before income taxes attributable to Health Management Associates, Inc. | |||||||||
| 350,472 | (24,595) | (16,363) | (22,324) | 287,190 | |||||
| Provision for income taxes | (130,594) | 9,531 | 6,341 | 8,651 | (106,071) | ||||
| Income from continuing operations attributable to Health Management Associates, Inc. common stockholders | |||||||||
| $ 219,878 | $ (15,064) | $ (10,022) | $ (13,673) | $ 181,119 | |||||
| Earnings per share from continuing operations attributable to Health Management Associates, Inc. common stockholders: | |||||||||
| Basic | $ 0.87 | $ (0.06) | $ (0.04) | $ (0.05) | $ 0.72 | ||||
| Diluted | $ 0.86 | $ (0.06) | $ (0.04) | $ (0.05) | $ 0.71 | ||||
Health Management Associates, Inc.John C. Merriwether, 239-598-3131Vice President of Financial Relations
Source: Health Management Associates, Inc.
NEW YORK--(BUSINESS WIRE)-- Martin Somelofske has joined Hay Group as a Senior Principal and Northeast Practice Leader for Executive Compensation in Hay Group’s Metro New York office.
Martin Somelofske (Photo: Hay Group)
Martin joins Hay Group from PricewaterhouseCoopers, where he was a Managing Director. He brings over 20 years of experience providing executive compensation advisory services to a broad range of public and privately held organizations in diverse industries. Martin advises Boards and executives on all matters related to executive compensation and benefits.
Martin’s expertise centers on performance management, executive reward program design, and the alignment of reward programs with organizational and stakeholder value. In addition, Martin often assists clients with Board governance issues.
“We are thrilled to have Marty join Hay Group,” said Irv Becker, Hay Group’s US practice leader of executive compensation. “His strong technical background and client relationship experience will be great assets to our clients.”
Martin is a frequent speaker at national and regional conferences as well as presenting often to Boards and compensation committees. In addition to authoring several published articles, Martin has also made numerous presentations at universities and human resources conferences around the world including those in Dublin, Hong Kong, Seoul, Singapore, Beijing, Shanghai, and Guangzhou.
Martin holds an AB in economics (cum laude) from Georgetown University, a JD from Albany Law School of Union University and an MBA with a concentration in finance from the University of Michigan. He is a member of World at Work, and NASPP.
For more information, please contact Mitch Kent at 215 861 2315; mitch.kent@haygroup.com
Follow us on Twitter: @hay_group
About Hay Group: Hay Group is a global management consulting firm that works with leaders to transform strategy into reality. We develop talent, organize people to be more effective and motivate them to perform at their best. Our focus is on making change happen and helping people and organizations realize their potential. Visit www.haygroup.com
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50167103&lang=en
Hay GroupMitch Kent, 215-861-2315mitch.kent@haygroup.com
Source: Hay Group
HAYWARD, Calif., Feb. 13, 2012 /PRNewswire/ -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT), a leading developer and supplier of critical subsystems for the semiconductor capital equipment, flat panel, medical, energy and research industries, today reported its financial results for the fourth quarter and fiscal year 2011 ended December 30, 2011.
Revenue for the fourth quarter of 2011 was $86.9 million, a decrease of 17.5% from the third quarter of 2011 and a decrease of 27.8% from the same period a year ago. Semiconductor revenue was 79.6% of total revenue for the fourth quarter compared to 66.2% in the previous quarter and revenue outside the U.S. accounted for 29% of the total revenue for the fourth quarter compared to 28% for the previous quarter. Gross margin for the fourth quarter of 2011 was 11.0%, compared to 12.2% for the third quarter of 2011 and 12.3% for the fourth quarter a year ago.
The company recorded net income of $7.8 million, or $0.34 per share in the fourth quarter of 2011 compared to net income of $3.2 million, or $0.14 per share in the third quarter of 2011 and net income of $3.9 million, or $0.17 per share for the fourth quarter of 2010. An income tax benefit of $6.4 million was recorded in the fourth quarter of 2011. In the second quarter of 2009, UCT recorded a tax valuation allowance, reducing its consolidated deferred tax assets by $7.0 million. Each quarter, we have evaluated our cumulative profits along with other assumptions, in order to evaluate the reasonableness of maintaining the valuation allowance on our balance sheet. During Q4 2011, we determined that there was enough substantive evidence to reverse a majority of the valuation allowance. As a result, a tax benefit of $6.4 million, or $0.28 per share, was recorded during the fourth quarter of 2011.
For fiscal year 2011 revenue was $452.6 million, an increase of $9.5 million, or 2.1%, over 2010. Gross margin for fiscal year 2011 was 13.0% compared to 13.3% for the same period a year ago. The company recorded net income of $23.7 million, or $1.01 per share for fiscal year 2011 compared to net income of $20.1 million, or $0.87 per share, for fiscal year 2010. Net income for fiscal year 2011 includes the tax benefit of $6.4 million, or $0.28 per share resulting from the reversal of the valuation allowance reported in the results for the fourth quarter of 2011.
Cash at the end of the fourth quarter 2011 was $52.0 million, an increase of $14.1 million from the prior quarter. Net liquidity was $27.3 million, an increase of $15.0 million from the prior quarter.
Clarence Granger, Ultra Clean's Chairman and Chief Executive Officer, stated: "As anticipated we experienced lower demand during the fourth quarter, primarily from our high brightness LED customers. However, we are very pleased that we were able to exceed both our revenue and EPS guidance for the quarter. We believe that we are at the bottom of this market decline and expect our operating results to be significantly better in the next quarter. I am proud of the success we have had in maintaining a strong balance sheet during this period, as we were able to grow our cash position by $14.1 million for the quarter to an all-time high of $52.0 million."
Commenting on Ultra Clean's corporate guidance, Granger noted: "Revenue guidance for the first quarter 2012 is $105 million to $110 million, with earnings per share in the range of $0.15 to $0.18. This projection reflects increases in demand by our customers during the first quarter of 2012. We are forecasting a tax rate of 24% for the first quarter."
Ultra Clean will conduct a conference call today, Monday, February 13, beginning at 1:45 p.m. PST at 888-561-5097 (domestic) and 706-679-7569 (international). A replay of the webcast will be available for fourteen days following the conference call at 855-859-2056 (domestic) and 404-537-3406 (international). The confirmation number for the live broadcast and replay is 42265100 (all callers). The conference call will also be webcast live and be available for fourteen days on our website.
About Ultra Clean Holdings, Inc.
Ultra Clean Holdings, Inc. is a leading developer and supplier of critical subsystems for the semiconductor capital equipment, flat panel, medical, energy and research industries. Ultra Clean offers its customers an integrated outsourced solution for gas delivery systems and other subassemblies, improved design-to-delivery cycle times, component neutral design and manufacturing and component testing capabilities. Ultra Clean's customers are primarily original equipment manufacturers for the semiconductor capital equipment, flat panel, medical, energy and research industries. Ultra Clean is headquartered in Hayward, California. Additional information is available at www.uct.com.
Safe Harbor Statement
The foregoing information contains, or may be deemed to contain, "forward-looking statements" (as defined in the US Private Securities Litigation Reform Act of 1995) which reflect our current views with respect to future events and financial performance. We use words such as "anticipates,", "projection", "forecast", "believes," "plan," "expect," "future,"' "intends," "may," "will," "should," "estimates," "predicts," "potential," "continue" and similar expressions to identify these forward-looking statements. Forward looking statements included in this press release include estimates made with respect to our first quarter 2012 revenue and earnings per share, and our expectations regarding improvements in our operating results and the markets we serve for the first quarter of fiscal 2012. All forward-looking statements address matters that involve risks and uncertainties. Accordingly, our actual results may differ materially from the results predicted or implied by these forward- looking statements. These risks, uncertainties and other factors include, among others, those identified in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations'' and elsewhere in our annual report on Form 10-K for the year ended December 31, 2010 filed with the Securities and Exchange Commission. Ultra Clean Holdings, Inc. undertakes no obligation to publicly update or review any forward-looking statements, whether as a result of new information future developments or otherwise.
Ultra Clean Holdings, Inc | ||||||||
Condensed Consolidated Statements of Income | ||||||||
(Unaudited; in thousands, except per share data) | ||||||||
For the three months ended | For the twelve months ended | |||||||
December 30, 2011 | December 31, 2010 | December 30, 2011 | December 31, 2010 | |||||
Sales | $ 86,873 | $ 120,303 | $ 452,639 | $ 443,134 | ||||
Cost of goods sold | 77,278 | 105,532 | 393,647 | 383,993 | ||||
Gross profit | 9,595 | 14,771 | 58,992 | 59,141 | ||||
Operating expenses: | ||||||||
Research and development | 1,262 | 1,536 | 5,556 | 5,487 | ||||
Sales and marketing | 1,503 | 1,959 | 7,257 | 6,887 | ||||
General and administrative | 5,274 | 5,516 | 22,633 | 21,290 | ||||
Total operating expenses | 8,039 | 9,011 | 35,446 | 33,664 | ||||
Income from operations | 1,556 | 5,760 | 23,546 | 25,477 | ||||
Interest and other income (expense), net | (96) | (131) | (1,106) | (667) | ||||
Income before income taxes | 1,460 | 5,629 | 22,440 | 24,810 | ||||
Income tax provision (benefit) | (6,341) | 1,733 | (1,294) | 4,713 | ||||
Net income | $ 7,801 | $ 3,896 | $ 23,734 | $ 20,097 | ||||
Net income per share: | ||||||||
Basic | $ 0.34 | $ 0.18 | $ 1.05 | $ 0.92 | ||||
Diluted | $ 0.34 | $ 0.17 | $ 1.01 | $ 0.87 | ||||
Shares used in computing | ||||||||
net income per share: | ||||||||
Basic | 22,850 | 22,051 | 22,689 | 21,799 | ||||
Diluted | 23,279 | 23,030 | 23,437 | 22,975 | ||||
Ultra Clean Holdings, Inc | ||||
Condensed Consolidated Balance Sheets | ||||
(Unaudited; in thousands) | ||||
December 30, | December 31, | |||
ASSETS | 2011 | 2010 | ||
Current assets: | ||||
Cash and cash equivalents | $ 52,013 | $ 34,654 | ||
Accounts receivable | 40,830 | 54,589 | ||
Inventory | 55,473 | 59,288 | ||
Other current assets | 12,000 | 5,935 | ||
Total current assets | 160,316 | 154,466 | ||
Equipment and leasehold improvements, net | 10,009 | 8,971 | ||
Purchased intangibles, net | 8,987 | 8,987 | ||
Other non-current assets | 5,183 | 571 | ||
Total assets | $ 184,495 | $ 172,995 | ||
LIABILITIES & STOCKHOLDERS' EQUITY | ||||
Current liabilities: | ||||
Bank borrowings | $ 2,931 | $ 4,110 | ||
Accounts payable | 29,379 | 45,957 | ||
Other current liabilities | 10,628 | 7,654 | ||
Total current liabilities | 42,938 | 57,721 | ||
Bank debt and other long-term liabilities | 24,272 | 27,765 | ||
Total liabilities | 67,210 | 85,486 | ||
Stockholders' equity: | ||||
Common stock | 105,501 | 99,459 | ||
Retained earnings/(deficit) | 11,784 | (11,950) | ||
Total stockholders' equity | 117,285 | 87,509 | ||
Total liabilities and stockholders' equity | $ 184,495 | $ 172,995 | ||
SOURCE Ultra Clean Holdings, Inc.
More Press Releases
View Older Stories-
The Victoria Advocate Newspaper Engages ACI as Distribution Partner
-
President of Community Management Concepts of Jacksonville Leads Local CAI Chapter
-
Rackspace Hosting Reports Fourth Quarter 2011 Results
-
Lawrence A. Selzer to Join Plum Creek Board of Directors
-
Nextgen Distribution and Objectivity, Inc. Announce Strategic Partnership to Address Australian Big Data Marketplace
-
S&T Bank Adds Financial Responsibility to the Lesson Plan as Part of Teach Children to Save® Campaign
-
Fitch Affirms Chandler, AZ Spectrum ID Bonds at 'AA-'; Outlook Stable
-
Notice From the Securities Arbitration Law Firm of Stuart D. Meissner LLC to All Customers Who Invested in Freddie Mac and Fannie Mae Preferred Securities
-
Lord Abbett Launches Enhanced Individual Investor Website
-
RTI Completes Remmele Acquisition to Expand Downstream Opportunities
-
Tarsis Closes Financing for $1.2 Million
-
Atlanta Carpet Cleaner Offers Carpet Cleaning Coupons Online
-
Alliance Distributors Holding Inc. Reports December 31, 2011 Financial Results
-
Airlines for America Says White House Budget Proposal Would Offset Deficit on Backs of Airline Customers
-
ION Announces Fourth Quarter and Year-End 2011 Earnings and Conference Call Schedule
-
Power Solutions International, Inc. Announces Preliminary Fourth Quarter 2011 Results
-
Raytheon Delivers First International Maritime Surveillance Radar to Boeing
-
Total Selects SGI for World’s Largest Commercial HPC System
-
The Hartford Mutual Funds’ Board Approves Move Of 11 Fixed Income Funds To Sub-advisor Wellington Management
-
The GEO Group Announces Date for Fourth Quarter 2011 Earnings Release and Conference Call
-
Tarsis Closes Financing for $1.2 Million
-
Vertex Announces Webcast of its Presentations at Three Investor Conferences
-
Fitch: U.S. Natural Gas Exports Face Long-Term Challenges
-
Insight Launches InsightCloud Solution Center with an Enhanced Shopping Experience for Cloud-Based Messaging
-
Cynthia and Edsel B. Ford II Named Honorary Chairs for The Elegance at Hershey
-
Covance to Present at Leerink Swann 2012 Global Healthcare Conference
-
Statement From L. Hunter Limbaugh, Chair of the Board of the American Diabetes Association, Regarding the Obama Administration's Fiscal Year 2013 Budget
-
Feeding America Applauds New Federal Budget Request
-
Bloom Investment Counsel Provides Investment Update
-
IIROC: Resume, Adeptron Technologies Corporation
-
Medisafe 1 Technologies to Start the $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share
-
Bloom Investment Counsel Provides Investment Update
-
New Amil Dental Website
-
LivePerson Announces Fourth Quarter and Full Year 2011 Financial Results
-
A 'FONZ' Welcome Awaits Guests of Hotel Near National Zoo
-
TTK Partners, LLC Opens Detroit Office
-
DuPont and Yingli Green Energy Enter $100 Million Strategic Agreement
-
Fitch Downgrades Long-term IDR of Santander Bancorp
-
Lender Processing Services Reports Fourth Quarter and Full Year 2011 Earnings
-
Synopsys Announces Industry's First HDMI 1.4 PHY IP in 28-nanometer Processes for Multiple Foundries
-
Websense to Host 8th Annual Financial Analyst Briefing
-
Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference
-
Intrusion Inc. Announces Fourth Quarter and Annual Results
-
Patriot Coal Receives Mountaineer Guardian Safety Award at Campbell's Creek Complex
-
RPX Announces Fourth Quarter and Fiscal Year 2011 Financial Results
-
SciQuest to Webcast Analyst and Investor Day Presentations
-
Exponent Authorizes Additional $35 Million for Stock Repurchase
-
FIS Announces Fourth Quarter and Full Year 2011 Results
-
Standex Announces Second Quarter Results and Expected Divestiture of Air Distribution Products Group
-
Seattle Genetics Reports Fourth Quarter and Year 2011 Financial Results
